Endorepellin-evoked autophagy contributes to angiostasis

Journal of Biological Chemistry

Volumn 291, Issue 37, 2016, Pages 19245-19256

  Goyal, Atul ^a   Gubbiotti, Maria A ^a   Chery, Daphney R ^b   Han, Lin ^b   Iozzo, Renato V ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELL MEMBRANES; CELLS; CYTOLOGY; ENZYMES; MAMMALS; SURFACE ROUGHNESS;

AMP-ACTIVATED KINASE; ANGIOSTATIC MOLECULES; AUTOPHAGOSOMES; C-TERMINAL DOMAINS; CO-LOCALIZATIONS; ENDOREPELLIN; MAMMALIAN TARGET; NUTRIENT DEPRIVATION;

ENDOTHELIAL CELLS;

BECLIN 1; CELL PROTEIN; ENDOREPELLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REGULATOR PROTEIN; TORIN 1 PROTEIN; UNCLASSIFIED DRUG; ADENYLATE KINASE; BECN1 PROTEIN, HUMAN; ENDOREPELLIN PROTEIN, HUMAN; KDR PROTEIN, HUMAN; LACTOSYLCERAMIDE; LACTOTRIAOSYLCERAMIDE; PEPTIDE FRAGMENT; PROTEOHEPARAN SULFATE; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; AUTOPHAGOSOME; AUTOPHAGY; CELL SIZE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; YOUNG MODULUS; METABOLISM; ULTRASTRUCTURE;

ADENYLATE KINASE; AUTOPHAGY; BECLIN-1; ELASTIC MODULUS; HEPARAN SULFATE PROTEOGLYCANS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTOSYLCERAMIDES; PEPTIDE FRAGMENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84987650441     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.740266     Document Type: Article

References (85)

1. Iozzo, R. V. (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6, 646-656
2. Iozzo, R. V., and Schaefer, L. (2015) Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol. 42, 11-55
3. Farach-Carson, M. C., Warren, C. R., Harrington, D. A., and Carson, D. D. (2014) Border patrol: insights into the unique role of perlecan/ heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 34, 64-79
4. Noonan, D. M., Fulle, A., Valente, P., Cai, S., Horigan, E., Sasaki, M., Yamada, Y., and Hassell, J. R. (1991) The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939-22947
5. Murdoch, A. D., Dodge, G. R., Cohen, I., Tuan, R. S., and Iozzo, R. V. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan): a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267, 8544-8557
6. Carson, D. D., Tang J.-P., and Julian, J. (1993) Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev. Biol. 155, 97-106
7. Handler, M., Yurchenco, P. D., and Iozzo, R. V. (1997) Developmental expression of perlecan during murine embryogenesis. Dev. Dyn. 210, 130-145
8. Whitelock, J. M., Graham, L. D., Melrose, J., Murdoch, A. D., Iozzo, R. V., and Underwood, P. A. (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol. 18, 163-178
9. Lord, M. S., Chuang, C. Y., Melrose, J., Davies, M. J., Iozzo, R. V., and Whitelock, J. M. (2014) The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol. 35, 112-122
10. Christianson, H. C., and Belting, M. (2014) Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol. 35, 51-55
11. Jochmann, K., Bachvarova, V., and Vortkamp, A. (2014) Heparan sulfate as a regulator of endochondral ossification and osteochondroma development. Matrix Biol. 34, 55-63
12. Wilusz, R. E., Sanchez-Adams, J., and Guilak, F. (2014) The structure and function of the pericellular matrix of articular cartilage. Matrix Biol. 39, 25-32
13. Lord, M. S., Jung, M., Cheng, B., and Whitelock, J. M. (2014) Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1. Matrix Biol. 35, 123-131
14. Jung, M., Lord, M. S., Cheng, B., Lyons, J. G., Alkhouri, H., Hughes, J. M., McCarthy, S. J., Iozzo, R. V., and Whitelock, J. M. (2013) Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing. J. Biol. Chem. 288, 3289-3304
15. Nugent, M. A., Nugent, H. M., Iozzo, R. V., Sanchack, K., and Edelman, E. R. (2000) Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 97, 6722-6727
16. Fuki, I. V., Iozzo, R. V., and Williams, K. J. (2000) Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. J. Biol. Chem. 275, 25742-25750
17. Ning, L., Xu, Z., Furuya, N., Nonaka, R., Yamada, Y., and Arikawa-Hirasawa, E. (2015) Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle. Matrix Biol. 48, 26-35
18. Cohen, I. R., Murdoch, A. D., Naso, M. F., Marchetti, D., Berd, D., and Iozzo, R. V. (1994) Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res. 54, 5771-5774
19. Mathiak, M., Yenisey, C., Grant, D. S., Sharma, B., and Iozzo, R. V. (1997) A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. Cancer Res. 57, 2130-2136
20. Iozzo, R. V., Zoeller, J. J., and Nyström, A. (2009) Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis. Mol. Cells 27, 503-513
21. Iozzo, R. V., and Sanderson, R. D. (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell Mol. Med. 15, 1013-1031
22. Grindel, B. J., Martinez, J. R., Pennington, C. L., Muldoon, M., Stave, J., Chung, L. W., and Farach-Carson, M. C. (2014) Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol. 36, 64-76
23. Poluzzi, C., Iozzo, R. V., and Schaefer, L. (2016) Endostatin and endorepellin: a common route of action for similar angiostatic cancer avengers. Adv. Drug Deliv. Rev. 97, 156-173
24. Zoeller, J. J., McQuillan, A., Whitelock, J., Ho, S.-Y., and Iozzo, R. V. (2008) A central function for perlecan in skeletal muscle and cardiovascular development. J. Cell Biol. 181, 381-394
25. Iozzo, R. V., Pillarisetti, J., Sharma, B., Murdoch, A. D., Danielson, K. G., Uitto, J., and Mauviel, A. (1997) Structural and functional characterization of the human perlecan gene promoter: transcriptional activation by transforming factor-ô via a nuclear factor 1-binding element. J. Biol. Chem. 272, 5219-5228
26. Sharma, B., and Iozzo, R. V. (1998) Transcriptional silencing of perlecan gene expression by interferon-ô. J. Biol. Chem. 273, 4642-4646
27. Peysselon, F., and Ricard-Blum, S. (2014) Heparin-protein interactions: from affinity and kinetics to biological roles: application to an interaction network regulating angiogenesis. Matrix Biol. 35, 73-81
28. Iozzo, R. V., and San Antonio, J. D. (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108, 349-355
29. Whitelock, J. M., Melrose, J., and Iozzo, R. V. (2008) Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174-11183
30. Kaji, T., Yamamoto, C., Oh-i, M., Fujiwara, Y., Yamazaki, Y., Morita, T., Plaas, A. H., and Wight, T. N. (2006) The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells. Biochim. Biophys. Acta 1760, 1465-1474
31. Neill, T., Schaefer, L., and Iozzo, R. V. (2014) Instructive roles of extracellular matrix on autophagy. Am. J. Pathol. 184, 2146-2153
32. Sharma, B., Handler, M., Eichstetter, I., Whitelock, J. M., Nugent, M. A., and Iozzo, R. V. (1998) Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 102, 1599-1608
33. Gustafsson, E., Almonte-Becerril, M., Bloch, W., and Costell, M. (2013) Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro. PLoS ONE 8, e53715
34. Mongiat, M., Sweeney, S. M., San Antonio, J. D., Fu, J., and Iozzo, R. V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238- 4249
35. Arpino, V., Brock, M., and Gill, S. E. (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 44-46, 247-254
36. Wells, J. M., Gaggar, A., and Blalock, J. E. (2015) MMP generated matrikines. Matrix Biol. 44-46, 122-129
37. Deryugina, E. I., and Quigley, J. P. (2015) Tumor angiogenesis: MMPmediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 44-46, 94-112
38. Rohani, M. G., and Parks, W. C. (2015) Matrix remodeling by MMPs during wound repair. Matrix Biol. 44-46, 113-121
39. Duarte, S., Baber, J., Fujii, T., and Coito, A. J. (2015) Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 44- 46, 147-156
40. Vadon-Le Goff, S., Hulmes, D. J., and Moali, C. (2015) BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol. 44-46, 14-23
41. Apte, S. S., and Parks, W. C. (2015) Metalloproteinases: A parade of functions in matrix biology and an outlook for the future. Matrix Biol. 44-46, 1-6
42. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005) BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080-7087
43. Goyal, A., Pal, N., Concannon, M., Paul, M., Doran, M., Poluzzi, C., Sekiguchi, K., Whitelock, J. M., Neill, T., and Iozzo, R. V. (2011) Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2). J. Biol. Chem. 286, 25947-25962
44. Willis, C. D., Poluzzi, C., Mongiat, M., and Iozzo, R. V. (2013) Endorepellin laminin-like globular repeat 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells. FEBS J. 280, 2271-2284
45. Goyal, A., Poluzzi, C., Willis, C. D., Smythies, J., Shellard, A., Neill, T., and Iozzo, R. V. (2012) Endorepellin affects angiogenesis by antagonizing diverse VEGFR2- evoked signaling pathways: transcriptional repression of HIF-1α and VEGFA and concurrent inhibition of NFAT1 activation. J. Biol. Chem. 287, 43543- 43556
46. Bix, G., Castello, R., Burrows, M., Zoeller, J. J., Weech, M., Iozzo, R. A., Cardi, C., Thakur, M. L., Barker, C. A., Camphausen, K., and Iozzo, R. V. (2006) Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J. Natl. Cancer Inst. 98, 1634-1646
47. Poluzzi, C., Casulli, J., Goyal, A., Mercer, T. J., Neill, T., and Iozzo, R. V. (2014) Endorepellin evokes autophagy in endothelial cells. J. Biol. Chem. 289, 16114-16128
48. Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., and Gray, N. S. (2009) An ATPcompetitive mammalian target of rapamycin inhibitor reveals rapamycinresistant functions of mTORC1. J. Biol. Chem. 284, 8023-8032
49. Mathur, A. B., Truskey, G. A., and Reichert, W. M. (2000) Atomic force and total internal reflection fluorescence microscopy for the study of force transmission in endothelial cells. Biophys. J. 78, 1725-1735
50. Lekka, M. (2016) Discrimination between normal and cancerous cells using AFM. Bionanoscience. 6, 65-80
51. Levine, B., and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42
52. Kuhajda, F. P. (2008) AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int. J. Obes. 32, S36-S41
53. Kim, J., Kundu, M., Viollet, B., Guan K.-L.(2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141
54. Brill, A., Elinav, H., and Varon, D. (2004) Differential role of platelet granular mediators in angiogenesis. Cardiovasc. Res. 63, 226-235
55. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. (2003) Angiogenesis assays: a critical overview. Clin. Chem. 49, 32-40
56. Choi, A. M., Ryter, S. W., and Levine, B. (2013) Autophagy in human health and disease. New Engl. J. Med. 368, 651-662
57. Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., and Thompson, C. B. (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248
58. Du, J., Teng, R.-J., Guan, T., Eis, A., Kaul, S., Konduri, G. G., and Shi, Y. (2012) Role of autophagy in angiogenesis in aortic endothelial cells. Am. J. Physiol. Cell Physiol. 302, C383-C391
59. Kumar, S., Guru, S. K., Pathania, A. S., Kumar, A., Bhushan, S., and Malik, F. (2013) Autophagy triggered by magnolol derivative negatively regulates angiogenesis. Cell Death. Dis. 4, e889
60. Braet, F., Seynaeve, C., De Zanger, R., and Wisse, E. (1998) Imaging surface and submembranous structures with the atomic force microscope: a study on living cancer cells, fibroblasts and macrophages. J. Microsc. 190, 328-338
61. Liang, J., and Mills, G. B. (2013) AMPK: A contextual oncogene or tumor suppressor? Cancer Res. 73, 2929-2935
62. Lee, J. W., Park, S., Takahashi, Y., and Wang, H.-G.(2010) The association of AMPK with ULK1 regulates autophagy. PLoS ONE 5, e15394
63. Järveläinen, H., Sainio, A., and Wight, T. N. (2015) Pivotal role for decorin in angiogenesis. Matrix Biol. 43, 15-26
64. Gubbiotti, M. A., Neill, T., Frey, H., Schaefer, L., and Iozzo, R. V. (2015) Decorin is an autophagy-inducible proteoglycan and is required for proper in vivo autophagy. Matrix Biol. 48, 14-25
65. Gubbiotti, M. A., and Iozzo, R. V. (2015) Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept. Matrix Biol. 48, 6-13
66. Buraschi, S., Neill, T., Goyal, A., Poluzzi, C., Smythies, J., Owens, R. T., Schaefer, L., Torres, A., and Iozzo, R. V. (2013) Decorin causes autophagy in endothelial cells via Peg3. Proc. Natl. Acad. Sci. U.S.A. 110, E2582-E2591
67. Goyal, A., Neill, T., Owens, R. T., Schaefer, L., and Iozzo, R. V. (2014) Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. Matrix Biol. 34, 46-54
68. Yu, L., McPhee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu, Z., Wan, F., Hailey, D. W., Oorschot, V., Klumperman, J., Baehrecke, E. H., and Lenardo, M. J. (2010) Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465, 942-946
69. Neill, T., Schaefer, L., and Iozzo, R. V. (2015) Decoding the matrix: instructive roles of proteoglycan receptors. Biochemistry 54, 4583-4598
70. Vigetti, D., Viola, M., Karousou, E., De Luca, G., and Passi, A. (2014) Metabolic control of hyaluronan synthases. Matrix Biol. 35, 8-13
71. Hascall, V. C., Wang, A., Tammi, M., Oikari, S., Tammi, R., Passi, A., Vigetti, D., Hanson, R. W., and Hart, G. W. (2014) The dynamic metabolism of hyaluronan regulates the cytosolic concentration of UDP-GlcNAc. Matrix Biol. 35, 14-17
72. Wang, A., Sankaranarayanan, N. V., Yanagishita, M., Templeton, D. M., Desai, U. R., Sugahara, K., Wang, C. P., and Hascall, V. C. (2015) Heparin interaction with a receptor on hyperglycemic dividing cells prevents intracellular hyaluronan synthesis and autophagy responses in models of type 1 diabetes. Matrix Biol. 48, 36-41
73. Vigetti, D., Clerici, M., Deleonibus, S., Karousou, E., Viola, M., Moretto, P., Heldin, P., Hascall, V. C., De Luca, G., and Passi, A. (2011) Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J. Biol. Chem. 286, 7917-7924
74. Cannon, J. E., Upton, P. D., Smith, J. C., and Morrell, N. W. (2010) Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists. Br. J. Pharmacol. 161, 140-149
75. Nguyen, T. M., Subramanian, I. V., Xiao, X., Ghosh, G., Nguyen, P., Kelekar, A., and Ramakrishnan, S. (2009) Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels. J. Cell Mol. Med. 13, 3687-3698
76. Nguyen, T. M., Subramanian, I. V., Kelekar, A., and Ramakrishnan, S. (2007) Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood 109, 4793- 4802
77. Pan, C. C., Shah, N., Kumar, S., Wheeler, S. E., Cinti, J., Hoyt, D. G., Beattie, C. E., An, M., Mythreye, K., Rakotondraibe, L. H., and Lee, N. Y. (2016) Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. Oncotarget 10.18632/oncotarget.9307
78. Liu, J., Copland, D. A., Theodoropoulou, S., Chiu, H. A., Barba, M. D., Mak, K. W., Mack, M., Nicholson, L. B., and Dick, A. D. (2016) Impairing autophagy in retinal pigment epithelium leads to inflammasome activation and enhanced macrophage-mediated angiogenesis. Sci. Rep. 6, 20639
79. Dimitriadis, E. K., Horkay, F., Maresca, J., Kachar, B., and Chadwick, R. S. (2002) Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys. J. 82, 2798-2810
80. Nikolaev, N. I., Müller, T., Williams, D. J., and Liu, Y. (2014) Changes in the stiffness of human mesenchymal stem cells with the progress of cell death as measured by atomic force microscopy. J. Biomech. 47, 625-630
81. Neill, T., Torres, A., Buraschi, S., Owens, R. T., Hoek, J. B., Baffa, R., and Iozzo, R. V. (2014) Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin. J. Biol. Chem. 289, 4952-4968
82. Rudnicka, L., Varga, J., Christiano, A. M., Iozzo, R. V., Jimenez, S. A., and Uitto, J. (1994) Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. J. Clin. Invest. 93, 1709-1715
83. Ryynänen, M., Ryynänen, J., Sollberg, S., Iozzo, R. V., Knowlton, R. G., and Uitto, J. (1992) Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J. Clin. Invest. 89, 974-980
84. Baker, M., Robinson, S. D., Lechertier, T., Barber, P. R., Tavora, B., D'Amico, G., Jones, D. T., Vojnovic, B., and Hodivala-Dilke, K. (2012) Use of the mouse aortic ring assay to study angiogenesis. Nat. Protoc. 7, 89-104
85. Iozzo, R. V., Chakrani, F., Perrotti, D., McQuillan, D. J., Skorski, T., Calabretta, B., and Eichstetter, I. (1999) Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 96, 3092-3097